| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.65 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |